Bringing the fundamentals into focus…
Back to Inhibrx Biosciences, Inc.
How Inhibrx Biosciences, Inc. stacks up
INBX · against 458 other Healthcare companies of similar size
Profitability
0/ 100
Near the bottom of its peers.
Ranked #458 of 459 · scores higher than 0% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 0–9, including INBX · Click a bar to see the companies
Why profitability scores 0?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 99% of peers. Operating margin: -10386.5% vs peer median 7.1%
- a lower return on assets: weaker than 98% of peers. Return on assets: -89.6% vs peer median 1.7%
- Return on invested capital is not reported, so it is left out of the score.
Metric by metric
Position: dot = INBX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | INBX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 434 reported | Not reported | 5.3% | — | — | 33% |
| Operating marginHigher is better · 430 reported | -10386.5% | 7.1% | 1% | 33% | |
| Return on assetsHigher is better · 444 reported | -89.6% | 1.8% | 2% | 33% | |
| Return on equityHigher is better · 427 reported | -1773.6% | 3.1% | 0% | Context only | |
| Gross marginHigher is better · 478 reported | 0.0% | 48.1% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around INBX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 3 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 3 | 11.2B DKK (≈$1.7B) | 99 | 59 | |
| 3 | 914M USD | 99 | 81 | |
| 451 | 1.0B USD | 1 | 32 | |
| 451 | 825M USD | 1 | 24 | |
| 451 | 1.2B USD | 1 | 21 | |
| 451 | 1.3B USD | 1 | 44 | |
| 458 | 1.2B USD | 0 | 6 | |
| 458 | 952M USD | 0 | 3 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score